R&D
Magnifying glass over years including 2026

Looking ahead to 2026 in biopharma

A look forward to trends to come in 2026, including AI-driven drug development, advanced modalities, and cardiometabolic disease therapies.

Sales & Marketing

Digital

Market Access

Market Access
Data representation of Europe

European biopharma at a crossroads

If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D